Annual Shareholders Equity
$446.82 M
-$48.85 M-9.86%
December 31, 2024
Summary
- As of March 4, 2025, MLTX annual stockholders equity is $446.82 million, with the most recent change of -$48.85 million (-9.86%) on December 31, 2024.
- During the last 3 years, MLTX annual shareholders equity has risen by +$458.47 million (+3937.05%).
- MLTX annual shareholders equity is now -9.86% below its all-time high of $495.68 million, reached on December 31, 2023.
Performance
MLTX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$446.82 M
-$41.37 M-8.47%
December 31, 2024
Summary
- As of March 4, 2025, MLTX quarterly stockholders equity is $446.82 million, with the most recent change of -$41.37 million (-8.47%) on December 31, 2024.
- Over the past year, MLTX quarterly shareholders equity has dropped by -$41.37 million (-8.47%).
- MLTX quarterly shareholders equity is now -17.64% below its all-time high of $542.55 million, reached on March 31, 2024.
Performance
MLTX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
MLTX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.9% | -8.5% |
| 3 y3 years | +3937.1% | +963.9% |
| 5 y5 years | +3937.1% | +963.9% |
MLTX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -9.9% | +3937.1% | -17.6% | +3937.1% |
| 5 y | 5-year | -9.9% | +3937.1% | -17.6% | +3937.1% |
| alltime | all time | -9.9% | +3937.1% | -17.6% | +3937.1% |
MoonLake Immunotherapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $446.82 M(-9.9%) | $446.82 M(-8.5%) |
| Sep 2024 | - | $488.20 M(-6.2%) |
| Jun 2024 | - | $520.66 M(-4.0%) |
| Mar 2024 | - | $542.55 M(+9.5%) |
| Dec 2023 | $495.68 M | $495.68 M(+16.6%) |
| Sep 2023 | - | $424.93 M(-13.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $489.80 M(+1066.2%) |
| Mar 2023 | - | $42.00 M(-14.1%) |
| Dec 2022 | $48.90 M(-519.9%) | $48.90 M(-11.6%) |
| Sep 2022 | - | $55.29 M(-13.0%) |
| Jun 2022 | - | $63.51 M(-645.4%) |
| Dec 2021 | -$11.64 M | -$11.64 M |
FAQ
- What is MoonLake Immunotherapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual shareholders equity year-on-year change?
- What is MoonLake Immunotherapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly shareholders equity year-on-year change?
What is MoonLake Immunotherapeutics annual stockholders equity?
The current annual shareholders equity of MLTX is $446.82 M
What is the all time high annual shareholders equity for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual stockholders equity is $495.68 M
What is MoonLake Immunotherapeutics annual shareholders equity year-on-year change?
Over the past year, MLTX annual stockholders equity has changed by -$48.85 M (-9.86%)
What is MoonLake Immunotherapeutics quarterly stockholders equity?
The current quarterly shareholders equity of MLTX is $446.82 M
What is the all time high quarterly shareholders equity for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly stockholders equity is $542.55 M
What is MoonLake Immunotherapeutics quarterly shareholders equity year-on-year change?
Over the past year, MLTX quarterly stockholders equity has changed by -$41.37 M (-8.47%)